-
-
-
-
-
-
-
Foundation Medicine and Natera Announce Broad Clinical Launch and Medicare Coverage of FoundationOne®Tracker
-
-
-
-
-
-
-
UnitedHealthcare Provides Commercial Coverage for FoundationOne®CDx and FoundationOne®Liquid CDx in Multiple Companion Diagnostic Indications
-
-
-
-
-
-
-
The Exceptional Women Awardees Foundation (EWA) announces selection of Dymeka Harrison, Chief Commercial Officer, Foundation Medicine, as a Winter 2022 Awardee
-
-
-
-
-
-
-
Foundation Medicine Appoints Dymeka Harrison as Chief Commercial Officer
-
-
-
-
-
-
-
Foundation Medicine Appoints Brian Alexander, M.D., M.P.H., as Chief Executive Officer
-
-
-
-
-
-
-
FDA Approves Foundation Medicine's FoundationOne®Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test with Multiple Companion Diagnostic Indications for Patients with Advanced Cancer
-
-
-
-
-
-
-
Foundation Medicine and Dana-Farber Present Data at ASCO20 Showing that Comprehensive Genomic Profiling Identified Co-Occurring Alterations that May Cause Treatment Resistance in Patients with METex14
-
170 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

